AU2002257890A1 - Method for replicating the hepatitis C virus - Google Patents
Method for replicating the hepatitis C virusInfo
- Publication number
- AU2002257890A1 AU2002257890A1 AU2002257890A AU2002257890A AU2002257890A1 AU 2002257890 A1 AU2002257890 A1 AU 2002257890A1 AU 2002257890 A AU2002257890 A AU 2002257890A AU 2002257890 A AU2002257890 A AU 2002257890A AU 2002257890 A1 AU2002257890 A1 AU 2002257890A1
- Authority
- AU
- Australia
- Prior art keywords
- replicating
- hepatitis
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 230000003362 replicative Effects 0.000 title 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR01/05732 | 2001-04-27 | ||
FR0105732A FR2824072B1 (en) | 2001-04-27 | 2001-04-27 | PROCESS FOR REPLICATION AND PRODUCTION OF HEPATITIS C VIRUS |
PCT/FR2002/001422 WO2002088338A2 (en) | 2001-04-27 | 2002-04-25 | Method for replicating the hepatitis c virus |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002257890A1 true AU2002257890A1 (en) | 2003-04-17 |
AU2002257890B2 AU2002257890B2 (en) | 2008-05-22 |
Family
ID=8862798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002257890A Ceased AU2002257890B2 (en) | 2001-04-27 | 2002-04-25 | Method for replicating the hepatitis C virus |
Country Status (12)
Country | Link |
---|---|
US (3) | US7314710B2 (en) |
EP (1) | EP1381675B1 (en) |
JP (1) | JP2004527252A (en) |
AT (1) | ATE335073T1 (en) |
AU (1) | AU2002257890B2 (en) |
CA (1) | CA2445596A1 (en) |
DE (1) | DE60213578T2 (en) |
ES (1) | ES2269684T3 (en) |
FR (1) | FR2824072B1 (en) |
MX (1) | MXPA03009736A (en) |
NZ (1) | NZ529037A (en) |
WO (1) | WO2002088338A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2824072B1 (en) * | 2001-04-27 | 2004-03-12 | Centre Nat Rech Scient | PROCESS FOR REPLICATION AND PRODUCTION OF HEPATITIS C VIRUS |
US7223787B2 (en) * | 2003-10-21 | 2007-05-29 | Board Of Regents, The University Of Texas System | Prenylation inhibitors reduce host cell permissiveness to viral replication |
EP1801116A1 (en) * | 2005-12-21 | 2007-06-27 | F. Hoffmann-La Roche Ag | HCV replicon shuttle vectors |
KR20100035637A (en) * | 2007-06-08 | 2010-04-05 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | Selective cell therapy for the treatment of renal failure |
GB0718446D0 (en) * | 2007-09-21 | 2007-10-31 | Prendergast Patrick T | Compositions and methods for the treatment of infection |
WO2010057015A1 (en) | 2008-11-14 | 2010-05-20 | Wake Forest University Health Sciences | Kidney structures and methods of forming the same |
WO2010057013A1 (en) | 2008-11-14 | 2010-05-20 | Wake Forest University Health Sciences | Selective cell therapy for the treatment of renal failure |
US20100173281A1 (en) * | 2009-01-06 | 2010-07-08 | Roche Palo Alto Llc | HCV NS3 protease replicon shuttle vectors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8923123D0 (en) * | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
US6159939A (en) * | 1995-06-23 | 2000-12-12 | Glenn; Jeffrey | Method for inhibition of viral morphogenesis |
WO1994025064A1 (en) * | 1993-05-04 | 1994-11-10 | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES | Hepatitis c virus cell propagation and related methods |
US20030054505A1 (en) * | 1997-09-26 | 2003-03-20 | Hong Jin | Recombinant rsv expression systems and vaccines |
WO1996024662A1 (en) * | 1995-02-10 | 1996-08-15 | Consiglio Nazionale Delle Ricerche | Process to 'in vitro' propagate the hepatitis c virus (hcv) in non lymphoblastoid animal cell cultures and products thereof |
US6127116A (en) * | 1995-08-29 | 2000-10-03 | Washington University | Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
US5998174A (en) * | 1997-05-12 | 1999-12-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Multigene vectors |
US6153421A (en) * | 1997-07-18 | 2000-11-28 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloned genomes of infectious hepatitis C viruses and uses thereof |
DE19915178A1 (en) * | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C virus cell culture system |
US6808876B1 (en) * | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
WO2002038793A2 (en) * | 2000-11-07 | 2002-05-16 | Anadys Pharmaceuticals, Inc. | Hepatitis c virus constructs characterized by high efficiency replication |
FR2824072B1 (en) * | 2001-04-27 | 2004-03-12 | Centre Nat Rech Scient | PROCESS FOR REPLICATION AND PRODUCTION OF HEPATITIS C VIRUS |
-
2001
- 2001-04-27 FR FR0105732A patent/FR2824072B1/en not_active Expired - Fee Related
-
2002
- 2002-04-25 AT AT02727692T patent/ATE335073T1/en not_active IP Right Cessation
- 2002-04-25 DE DE60213578T patent/DE60213578T2/en not_active Expired - Lifetime
- 2002-04-25 JP JP2002585619A patent/JP2004527252A/en active Pending
- 2002-04-25 CA CA002445596A patent/CA2445596A1/en not_active Abandoned
- 2002-04-25 WO PCT/FR2002/001422 patent/WO2002088338A2/en active IP Right Grant
- 2002-04-25 ES ES02727692T patent/ES2269684T3/en not_active Expired - Lifetime
- 2002-04-25 US US10/475,989 patent/US7314710B2/en not_active Expired - Fee Related
- 2002-04-25 EP EP02727692A patent/EP1381675B1/en not_active Expired - Lifetime
- 2002-04-25 NZ NZ529037A patent/NZ529037A/en unknown
- 2002-04-25 MX MXPA03009736A patent/MXPA03009736A/en active IP Right Grant
- 2002-04-25 AU AU2002257890A patent/AU2002257890B2/en not_active Ceased
-
2007
- 2007-10-02 US US11/865,954 patent/US7655406B2/en not_active Expired - Fee Related
-
2009
- 2009-12-09 US US12/633,890 patent/US20100159467A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002357049A1 (en) | Methods for preparing 0-desmethylvenlafaxine | |
AU2002210450A1 (en) | Maintaining virus detection software | |
HK1070287A1 (en) | Hepatitis c virus inhibitors | |
AU2001282528A1 (en) | Compounds having anti-hepatitis c virus effect | |
AU2003206862A1 (en) | Hepatitis b vaccines | |
HK1066245A1 (en) | Method for virus propagation | |
ZA200306040B (en) | Hepatitis B virus treatment. | |
AU2003260984A1 (en) | S-(-)-amlodipine nicotinate and process for the preparation thereof | |
AU2002257890A1 (en) | Method for replicating the hepatitis C virus | |
AU2292600A (en) | Varicella-zoster virus vaccines | |
EP1298117A3 (en) | Method for preparing bromofluorenes | |
AU2003256404A1 (en) | Hepatitis c virus assays | |
AU2002250101A1 (en) | Lithography method | |
AU2003230790A1 (en) | Hepatitis c virus sub-genomic replicons | |
AU2003289016A1 (en) | Method of distinguishing drug-resistance of hepatitis b virus | |
AU2002354841A1 (en) | Engineering oncolytic viruses | |
AU2002351795A1 (en) | Hepatitis x virus antigen | |
AU2001234644A1 (en) | Methods for inactivating viruses | |
AU2003263028A1 (en) | Mouse hepatitis virus detection | |
GB0111442D0 (en) | Method for preparing recombinant virus | |
AU2002327384A1 (en) | Remedies for hepatitis c | |
AU2006233207A1 (en) | Hepatitis C virus inhibitors | |
AU2002340558A1 (en) | Method for inhibiting the replication of viruses | |
AU2002328495A1 (en) | Hepatitis b virus proliferation inhibitor | |
AU2002342298A1 (en) | Methods for inactivating viruses |